Stelljes, M., Middeke, J. M., Bug, G., Wagner-Drouet, E., Müller, L. P., Schmid, C., . . . Schetelig, J. (2025). Disease risk but not remission status determines transplant outcomes in AML: Long-term outcomes of the ASAP trial : clinical trials and observations. Blood, 146(19), . https://doi.org/10.1182/blood.2025028730
Chicago-Zitierstil (17. Ausg.)Stelljes, Matthias, et al. "Disease Risk but Not Remission Status Determines Transplant Outcomes in AML: Long-term Outcomes of the ASAP Trial : Clinical Trials and Observations." Blood 146, no. 19 (2025). https://doi.org/10.1182/blood.2025028730.
MLA-Zitierstil (9. Ausg.)Stelljes, Matthias, et al. "Disease Risk but Not Remission Status Determines Transplant Outcomes in AML: Long-term Outcomes of the ASAP Trial : Clinical Trials and Observations." Blood, vol. 146, no. 19, 2025, https://doi.org/10.1182/blood.2025028730.